Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection

This article reviews the diagnoses and treatment of temporomandibular disorders (TMD) and outlines of the role of botulinum toxin (BoNT) in the treatment of myofacial TMD. This manuscript includes a brief history of the use of BoNT in the treatment of pain, the mechanism of action of BoNT, and the techniques for injections, adverse effects and contraindications when using BoNT to treat mayofacial pain caused by TMD.

• Publication year

  2015

• Venue

  Toxins

• Publication date

  2015-07-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/toxins7082791PMID 26213970PMCID 4549724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Psychosocial interventions for the management of chronic orofacial pain.

  2015cited by this paper
• Botulinum toxin: The Midas touch

  2014cited by this paper
• Unlocking the jaw: advanced imaging of the temporomandibular joint.

  2014cited by this paper
• Oromandibular dystonia: Long‐term management with botulinum toxin

  2013cited by this paper
• Temporomandibular Disorders, Masseteric Hypertrophy, and Cosmetic Masseter Reduction

  2012cited by this paper
• Concurrent OnabotulinumtoxinA Treatment of Cervical Dystonia and Concomitant Migraine

  2012cited by this paper
• Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.

  2012cited by this paper
• Diffusion of Botulinum Toxins

  2012cited by this paper
• Botulinum toxin for Frey's syndrome: a closer look at different treatment responses.

  2012cited by this paper
• Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine

  2011cited by this paper
• OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

  2010cited by this paper
• Treatment of Frey's syndrome with botulinum toxin type B

  2010cited by this paper
• OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

  2010cited by this paper
• OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

  2010cited by this paper
• Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis

  2009cited by this paper
• Repeated botulinum toxin type A injections to treat patients with Frey syndrome.

  2009cited by this paper
• A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy

  2008cited by this paper
• Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia.

  2008cited by this paper
• Treatment of Frey's syndrome with botulinum toxin.

  2007cited by this paper
• The emerging role of botulinum toxin in the treatment of temporomandibular disorders.

  2007cited by this paper
• Cost-effectiveness of treatments for temporomandibular disorders: biopsychosocial intervention versus treatment as usual.

  2007cited by this paper
• A Qualitative Systematic Review

  2006cited by this paper
• Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Tension-Type Headache: A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study

  2006cited by this paper
• Botulinum toxin type A for drooling in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study

  2006cited by this paper
• Botulinum toxin type A in the treatment of excessive gingival display.

  2005cited by this paper
• A Pilot Study of Botulinum Toxin A for Headache in Cervical Dystonia

  2005cited by this paper
• Referred Pain From the Trochlear Region in Tension‐Type Headache: A Myofascial Trigger Point From the Superior Oblique Muscle

  2005cited by this paper
• [Treatment of Frey's syndrome with botulinum toxin].

  2005cited by this paper
• Pharmacology of botulinum neurotoxins

  2004cited by this paper
• Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review.

  2004cited by this paper
• Reduction of Salivary Flow With Botulinum Toxin: Extended Report on 33 Patients with Drooling, Salivary Fistulas, and Sialadenitis

  2004cited by this paper
• Characteristics of subjects with secondary otalgia.

  2004influential reference
• A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease

  2004cited by this paper
• BOTULINUM TOXIN TREATMENT OF TEMPOROMANDIBULAR DISORDERS, MASSETERIC HYPERTROPHY, AND COSMETIC MASSETER REDUCTION

  2004cited by this paper
• Botulinum Toxin Type A in the Management of Oromandibular Dystonia and Bruxism

  2003cited by this paper
• Pharmacology of Botulinum Neurotoxins

  2003cited by this paper
• Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

  2003cited by this paper
• A randomized clinical trial of a tailored comprehensive care treatment program for temporomandibular disorders.

  2002cited by this paper
• Botulinum toxin A in the treatment of patients with Frey syndrome

  2002cited by this paper
• Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain

  2002cited by this paper
• The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial.

  2002cited by this paper
• Treatment of Temporomandibular Disorders with Botulinum Toxin

  2002cited by this paper
• The use of botulinum toxin type A in headache treatment

  2002cited by this paper
• Botulinum toxin: new treatment for temporomandibular disorders.

  2000cited by this paper
• Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study

  2000cited by this paper
• A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain.

  1997cited by this paper
• Identifying a neurobiologic basis for drug therapy in TMDs.

  1996cited by this paper
• Tinnitus in patients with temporomandibular joint internal derangement.

  1995cited by this paper
• Frey's syndrome: treatment with botulinum toxin.

  1995cited by this paper
• Oromandibular dystonia: Treatment of 96 patients with botulinum toxin A

  1994cited by this paper
• Long-term oral opioid therapy in patients with chronic nonmalignant pain.

  1992cited by this paper
• Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique.

  1992cited by this paper
• Botulinum Toxin Injection for the Treatment of Oromandibular Dystonia

  1989cited by this paper
• Ocular and periocular pain.

  1989cited by this paper
• "TMJ" triad of dysfunctions: a biologic basis of diagnosis and treatment.

  1984cited by this paper

• The Management of Myogenous Temporomandibular Disorders with Botulinum Toxin: A Narrative Review and Management Recommendations

  2026cites this paper
• Topographic Anatomy of the Lateral Pterygoid Muscle: Implications for Landmark-Guided Extraoral Interventions.

  2026cites this paper
• The Role of Injection of Botulinum Toxin in Lateral Pterygoid Muscle for Management of Temporomandibular Joint Disorders: A Systematic Review and Meta Analysis

  2025cites this paper
• BoNT Injection into Temporomandibular Joint Alleviates TMJ Pain in Forced Mouth Opening Mouse Model

  2025cites this paper
• Temporomandibular disorder presenting as chronic migraine; the diagnostic role of MRI and interdisciplinary evaluation: A clinical report.

  2025cites this paper
• Place de la toxine botulique A dans la prise en charge thérapeutique des douleurs orofaciales myofasciales chroniques : à propos d’un cas clinique

  2024cites this paper
• Efficacy and Safety of Botulinum Toxin in the Management of Temporomandibular Symptoms Associated with Sleep Bruxism: A Systematic Review

  2024cites this paper
• The effectiveness of botulinum toxin for temporomandibular disorders: A systematic review and meta-analysis

  2024cites this paper
• Efficacy of Botulinum Toxin Type A Injection on Masseter Hypertrophy

  2024cites this paper
• Current Status of Research on Botulinum Toxin Type A for the Treatment of Masticatory Muscle Pain

  2024cites this paper
• Effects of botulinum toxin type A on the masseter muscles of a patient with a temporomandibular joint disorder of muscular origin: A case report

  2024cites this paper
• Mitigating Immunogenicity by Coordinating Botulinum Toxin Treatments Between Aesthetics and Therapeutics

  2024cites this paper
• Awareness of Aesthetic and Therapeutic Crossover Usage of Botulinum Neurotoxin Type A

  2024cites this paper
• A retrospective study on the use of Botulinum toxin as part of first line of management in the treatment of myogenous TMD

  2023cites this paper
• Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials.

  2023cites this paper
• Persistent myogenic temporomandibular disorders: are navigation-guided botulinum toxin-A injections into the lateral pterygoid muscles effective?

  2023cites this paper
• Unilateral injection of botulinum toxin type A into the masseter muscle induces mandibular asymmetry in adolescent rats by suppressing the angular process growth.

  2023cites this paper
• Effect of Botulinum Toxin on Masticatory Muscle Pain in Patients with Temporomandibular Disorders: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

  2023cites this paper
• Congenital cranio-facial abnormalities in paediatric population: a systematic review on temporomandibular disorders.

  2023cites this paper
• Adverse effect of botulinum toxin-A injections on mandibular bone: A systematic review and meta-analysis.

  2023cites this paper
• Effectiveness of Botulinum Toxin on Hand Tremor Intensity and Upper Limb Function in Patients with Parkinson’s Disease: Results of a Systematic Review

  2023cites this paper
• Botulinum Toxin and Percutaneous Needle Electrolysis for the Treatment of Chronic Masticatory Myalgia

  2023cites this paper
• The use of platelet-rich plasma, hyaluronic acid, and botulinum toxin for the treatment of TMJ disorders

  2023cites this paper
• Prevalence of temporomandibular disorders in children and adolescents evaluated with Diagnostic Criteria for Temporomandibular disorders (DC/TMD): A systematic review with meta-analysis.

  2023cites this paper
• Bruxism and Botulinum Injection: Challenges and Insights

  2023cites this paper
• Are Dermal Fillers Dentistry?

  2022cites this paper
• Guidance to trigger point injection for treating myofascial pain syndrome: Intramuscular neural distribution of the quadratus lumborum

  2022cites this paper
• Trigger point injections for orofacial muscle pain: a narrative review

  2022cites this paper
• Guidelines for botulinum neurotoxin injection for facial contouring.

  2022cites this paper
• Botulinum Toxin, a Drug with Potential Interest for Dentists—An Introduction

  2022cites this paper
• Application of Botulinum Toxin in Temporomandibular Disorders: A Systematic Review of Randomized Controlled Trials (RCTs)

  2022cites this paper
• Temporomandibular Disorders for the General Dental Practitioner

  2022cites this paper
• Comparative study between usage of Platelet-Rich Plasma and Botulinum toxin-A injection in management of Myofascial pain dysfunction. (A Randomized Clinical Trial)

  2022cites this paper
• TNF-α levels and presence of SNP-308G/A of TNF-α gene in temporomandibular disorder patients

  2022cites this paper
• STRUCTURAL AND ULTRASTRUCTURAL EXAMINATION OF ANTI- ARTHRITIC EFFECT OF BEE VENOM IN

  2022influential citation
• Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome

  2022cites this paper
• Case Report: Capacity to Objectively Monitor the Response of a Chronic Pain Patient to Treatment

  2022cites this paper
• A Novel Injection Technique to the Lateral Pterygoid Muscle for Temporomandibular Disorders: A Cadaveric Study

  2021cites this paper
• Efficacy of dry needling in TMD treatment: clinical case report

  2021cites this paper
• Intramuscular Neural Distribution of the Serratus Anterior Muscle: Guidelines to the Injective Method for Treating Myofascial Pain Syndrome

  2021cites this paper
• Systematic Review Effectiveness of Botulinum Toxin in Managing Temporomandibular Disorders: A Systematic Review

  2021cites this paper
• Is low dose of botulinum toxin effective in controlling chronic pain in sleep bruxism, awake bruxism, and temporomandibular disorder?

  2021cites this paper
• Radiation Diagnostics in Treatment of Displacement of a Joint Disk of a Temp-Jaw Joint and Myofascial Disorders

  2021cites this paper
• Does the Use of Botulinum Toxin Reduce the Intensity of Myofascial Pain in Adult Patients? A Systematic Review and Meta-Analysis

  2021cites this paper
• The Application of Manual Techniques in Masticatory Muscles Relaxation as Adjunctive Therapy in the Treatment of Temporomandibular Joint Disorders

  2021cites this paper
• Emerging Potential of Exosomes in Regenerative Medicine for Temporomandibular Joint Osteoarthritis

  2020cites this paper
• Botulinum Toxin in Neurological Practice: Past, Present, Future

  2020cites this paper
• Impact Age in Treatment Myofacial Pain with Temporomandibular Joint Disorders by Botox Injection

  2020cites this paper
• Treatment of Localized and Referred Masticatory Myofascial Pain with Botulinum Toxin Injection

  2020cites this paper
• Uso da toxina botulínica no tratamento das desordens temporomandibulares: revisão integrativa

  2020cites this paper
• Botulinum toxin in the management of temporomandibular disorders: a systematic review.

  2020cites this paper
• Decreased mandibular cortical bone quality after botulinum toxin injections in masticatory muscles in female adults

  2020cites this paper
• MR-guided navigation for botulinum toxin injection in the lateral pterygoid muscle. First results in the treatment of temporomandibular joint disorders.

  2019cites this paper
• A complex treatment of irreducible displacement of the temporomandibular joint disc and myofascial pain disorders with the use of botulinum toxin

  2019cites this paper
• Cerebral palsy and bruxism: Effects of botulinum toxin injections—A randomized controlled trial

  2019cites this paper
• Electromyography assited application of botulinum toxin in pterygoid musculature for the treatment of masticatory myofascial pain

  2019cites this paper
• Evaluation of patient satisfaction after botulinum toxin A injection for the management of masticatory myofascial pain and dysfunction – A pilot study

  2019cites this paper
• Improvement in quality of life after botulinum toxin injection for temporomandibular disorder.

  2019cites this paper
• Botox for Migraine Headaches and Facial Pain

  2018cites this paper
• Botulinum Toxin A for Spastic Trismus Due to Brain Stem Encephalitis in a Pediatric Intensive Care Setting: A Unique Case Report

  2018cites this paper
• Botulinum Toxin in Dentistry

  2018influential citation
• BOTULINUM TOXIN TYPE-A…AN EVOLVING TREATMENT MODALITY IN THE MANAGEMENT OF TEMPOROMANDIBULAR JOINT DISC DISPLACEMENT

  2018cites this paper
• IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder

  2017cites this paper
• Use of botulinum toxin type a in temporomandibular disorder

  2017cites this paper
• Effectiveness and safety use of botulinal toxin compared to others medicinal alternatives in patients with focal dystonia

  2016cites this paper
• Shamel M et : Epidermal growth factor and botulinum toxin; Paralysis a bless? www.jrmds.in

  2016influential citation
• The effect of laser and botulinum toxin in the treatment of myofascial pain and mouth opening: A randomized clinical trial.

  2016cites this paper
• Epidermal Growth Factor (EGF) and Botulinum Toxin (BTX); Can Paralysis Be A Bless?

  2016cites this paper